Search

Author/Creator Greve, Bernhard

1. Efficacy and Safety of Rozanolixizumab in Moderate to Severe Generalized Myasthenia Gravis: A Phase 2 Randomized Control Trial. (9th February 2021)

Authors:
Bril, Vera; Benatar, Michael; Andersen, Henning; Vissing, John; Brock, Melissa; Greve, Bernhard; Kiessling, Peter; Woltering, Franz; Griffin, Laura; Van den Bergh, Peter
Other Names:
Benarik Josef author non-byline.; Beydoun Said author non-byline.; Blaes Franz author non-byline.; De Bleecker Jan author non-byline.; Freimer Miriam author non-byline.; Genge Angela author non-byline.; Grosskreutz Julian author non-byline.; Guerrero Sola Antonio author non-byline.; Guptill Jeffr...
Journal:
Neurology
Issue:
Volume 96:Number 6(2021)
Page Start:
e853
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study. Issue 5 (May 2023)

Authors:
Bril, Vera; Drużdż, Artur; Grosskreutz, Julian; Habib, Ali A; Mantegazza, Renato; Sacconi, Sabrina; Utsugisawa, Kimiaki; Vissing, John; Vu, Tuan; Boehnlein, Marion; Bozorg, Ali; Gayfieva, Maryam; Greve, Bernhard; Woltering, Franz; Kaminski, Henry J; Genge, Angela; Massie, Rami; Berube, Maxime; Br...
Journal:
Lancet neurology
Issue:
Volume 22:Issue 5(2023)
Page Start:
383
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search